StockTipsArenaBeta

BUY Divi's Laboratories Limited — Chandan Taparia, Motilal Oswal

BUYDivi's Laboratories Limited
Divi's Laboratories share price target & all analyst calls

byChandan Taparia, Motilal OswalHorizon: NA (inferred Swing (≤2wk))25 May 2026via ET Now

Entry₹6,600Stated
Target₹7,000
Total upside +6.06% (call closed)
Stop loss₹6,424-2.67% risk
At expiry₹6,5218 Jun 2026, 3:30 pm
Expired-1.20%
Follow Chandan Taparia for new calls(30% target hit, 259 closed calls)Get alertsWatch DIVISLAB for new buy/sell callsGet alertsSee 1 active Swing call on DIVISLABSee 149 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 25 Oct, 10:51 pm IST
3 supporting2 neutral0 opposing
Supports the BUY call (3)

Divi's FY26 net profit rises 17% to ₹2,568 crore

NewsGoogle News·30 May · 1w ago

(opens in new tab)

1500% Dividend Bonanza! Pharma Stock In Spotlight After Mega Payout; Record Date Announced

NewsGoogle News·24 May · 2w ago

(opens in new tab)

1 advisor has an active short-term BUY call on this stock

Advisor consensus · adjacent horizon·14 May · 4w ago

Neutral / worth noting (2)

Divi's Laboratories Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.

NSE · Outcome of Board Meeting·25 May · 2w ago

(opens in new tab)

Divi's Laboratories Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.

NSE · Outcome of Board Meeting·23 May · 2w ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Divi's Laboratories

All analyst calls on Divi's Laboratories

More from Chandan Taparia, Motilal Oswal

Every call and its outcome